Dyslipidemia is a physiological response in pregnancy driven by secretion of steroid hormone (e.g., progesterone), increased hepatic synthesis of triglycerides, and reduced lipoprotein lipase activity in adipose tissue (84). This evidence concerns the gene LPL and metabolic syndrome.